Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H29N2O |
Molecular Weight | 325.4678 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC2=CC=CC=C2
InChI
InChIKey=ZFQMTVNLDNXRNQ-UHFFFAOYSA-O
InChI=1S/C21H28N2O/c1-5-23(6-2,15-19-13-8-7-9-14-19)16-20(24)22-21-17(3)11-10-12-18(21)4/h7-14H,5-6,15-16H2,1-4H3/p+1
Molecular Formula | C21H29N2O |
Molecular Weight | 325.4678 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | NONE |
Denatonium, usually available as denatonium benzoate (trade names Bitrex) is the most bitter chemical compound known, with bitterness thresholds of 0.05 ppm for the benzoate and 0.01 ppm for the saccharide. Scientists at Macfarlan Smith, Ltd. of Edinburgh, Scotland discovered Bitrex during research on derivatives of the anesthetic lidocaine. The extremely bitter taste proved effective in reducing ingestion by humans and animals. Denatonium is commonly included in placebo medications used in clinical trials to match the bitter taste of certain medications. Denatonium activates bitter taste receptor, mainly, TAS2R4, TAS2R8, TAS2R10, TAS2R13 on many cell types and plays important roles in chemical release, ciliary beating and smooth muscle relaxation through intracellular Ca(2+)-dependent pathways.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9NYW5 Gene ID: 50832.0 Gene Symbol: TAS2R4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20022913 |
|||
Target ID: Q9NYV9 Gene ID: 50838.0 Gene Symbol: TAS2R13 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20022913 |
|||
Target ID: Q9NYW0 Gene ID: 50839.0 Gene Symbol: TAS2R10 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20022913 |
|||
Target ID: Q9NYW2 Gene ID: 50836.0 Gene Symbol: TAS2R8 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20022913 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Doses
Dose | Population | Adverse events |
---|---|---|
300 ppm single, ophthalmic Dose: 300 ppm Route: ophthalmic Route: single Dose: 300 ppm Sources: |
healthy, 27 years (range: 22–33 years) Health Status: healthy Age Group: 27 years (range: 22–33 years) Sex: M+F Sources: |
|
1 umol/kg single, intragastric Dose: 1 umol/kg Route: intragastric Route: single Dose: 1 umol/kg Sources: |
healthy, 29 years |
|
1.69 mg/mL single, respiratory Dose: 1.69 mg/mL Route: respiratory Route: single Dose: 1.69 mg/mL Sources: |
healthy, 34 years |
Other AEs: Asthma... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Asthma | 1 patient | 1.69 mg/mL single, respiratory Dose: 1.69 mg/mL Route: respiratory Route: single Dose: 1.69 mg/mL Sources: |
healthy, 34 years |
PubMed
Title | Date | PubMed |
---|---|---|
Immunocytochemical evidence for co-expression of Type III IP3 receptor with signaling components of bitter taste transduction. | 2001 |
|
Bitter taste transduced by PLC-beta(2)-dependent rise in IP(3) and alpha-gustducin-dependent fall in cyclic nucleotides. | 2001 Apr |
|
Soa genotype selectively affects mouse gustatory neural responses to sucrose octaacetate. | 2001 Apr 27 |
|
Taste receptor cells that discriminate between bitter stimuli. | 2001 Feb 23 |
|
Cellular responses of NG108-15 and SK-N-MC lines to sweet and bitter tastants as measured by extracellular acidification rates. | 2001 Jan 1 |
|
Covariation in individuals' sensitivities to bitter compounds: evidence supporting multiple receptor/transduction mechanisms. | 2001 Jul |
|
Effect of compound sequence on bitterness enhancement. | 2001 May |
|
Taste receptor cell responses to the bitter stimulus denatonium involve Ca2+ influx via store-operated channels. | 2002 Jun |
|
Rats fail to discriminate quinine from denatonium: implications for the neural coding of bitter-tasting compounds. | 2002 Mar 1 |
|
Role of the G-protein subunit alpha-gustducin in taste cell responses to bitter stimuli. | 2003 Oct 29 |
|
Was it necessary to add Bitrex (denatonium benzoate) to automotive products? | 2004 Jun |
|
Taste + odor interactions in compound aversion conditioning. | 2004 Nov |
|
Identification of ligands for two human bitter T2R receptors. | 2004 Sep |
|
Diverse bitter stimuli elicit highly similar patterns of Fos-like immunoreactivity in the nucleus of the solitary tract. | 2004 Sep |
|
Umami taste responses are mediated by alpha-transducin and alpha-gustducin. | 2004 Sep 1 |
|
In vivo imaging of C. elegans ASH neurons: cellular response and adaptation to chemical repellents. | 2005 Jan 12 |
|
Genomic organization, expression, and function of bitter taste receptors (T2R) in mouse and rat. | 2005 Jul 14 |
|
Haplotypes at the Tas2r locus on distal chromosome 6 vary with quinine taste sensitivity in inbred mice. | 2005 Jun 6 |
|
Differential covariation in taste responsiveness to bitter stimuli in rats. | 2005 Nov |
|
G-protein-dependent and -independent pathways in denatonium signal transduction. | 2005 Sep |
|
Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels. | 2006 Oct |
|
Exploratory behaviour in NO-dependent cyclase mutants of Drosophila shows defects in coincident neuronal signalling. | 2007 Aug 6 |
|
Functional characterization of human bitter taste receptors. | 2007 May 1 |
|
A non-invasive method for ending thumb- and fingersucking habits. | 2007 Oct |
|
The neural processing of taste. | 2007 Sep 18 |
|
Behavioral genetics and taste. | 2007 Sep 18 |
|
Adverse reactions associated with respirator fit testing of healthcare workers in British Columbia, Canada: a review of compensation claim cases. | 2007 Winter |
|
Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. | 2008 |
|
Norepinephrine is coreleased with serotonin in mouse taste buds. | 2008 Dec 3 |
|
Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. | 2008 Jan |
|
Responses of the ciliates tetrahymena and paramecium to vertebrate odorants and tastants. | 2008 Jan-Feb |
|
The impact of bittering agents on suicidal ingestions of antifreeze. | 2008 Jul |
|
Nasal solitary chemoreceptor cell responses to bitter and trigeminal stimulants in vitro. | 2008 Jun |
|
Intragastric infusion of denatonium conditions flavor aversions and delays gastric emptying in rodents. | 2008 Mar 18 |
|
The taste transduction channel TRPM5 is a locus for bitter-sweet taste interactions. | 2008 May |
|
Construction of a taste-blind medaka fish and quantitative assay of its preference-aversion behavior. | 2008 Nov |
|
Tonic activity of Galpha-gustducin regulates taste cell responsivity. | 2008 Nov 12 |
|
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. | 2008 Nov 13 |
|
Constructing quality profiles for taste compounds in rats: a novel paradigm. | 2008 Oct 20 |
|
Preferences of 14 rat strains for 17 taste compounds. | 2008 Oct 20 |
|
Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligands. | 2009 Mar |
|
A Drosophila gustatory receptor essential for aversive taste and inhibiting male-to-male courtship. | 2009 Oct 13 |
|
Chemoreception regulates chemical access to mouse vomeronasal organ: role of solitary chemosensory cells. | 2010 Jul 30 |
|
Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression. | 2010 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02759926
1 µmol/kg bodyweight (10mM) was administered as a bolus into the stomach through a nasogastric feeding tube.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25652218
Denatonium inhibits growth and induces apoptosis of airway epithelial cells. After treatment with 2 mM denatonium for 24 h, the expression of the anti-apoptotic protein Bcl-2 was significantly reduced and the release of cytochrome c and Smac/DIABLO from the mitochondria to the cytoplasm was drastically increased in human bronchial epithelial cell lines 16HBE. To examine whether denatonium induces mitochondrial damage in airway epithelial cells, was used transmission electron microscopy to examine the ultrastructures of human lung cancer cell line A549 treated with 2 mM denatonium. The control cells appeared to have normal mitochondria and mostly homogeneous cytoplasms, while A549 cells treated with denatonium showed large amplitude swelling of mitochondria.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:54 GMT 2025
by
admin
on
Mon Mar 31 17:58:54 GMT 2025
|
Record UNII |
4IK22DF4OU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DENATONIUM
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
100000087748
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
DTXSID9043770
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
SUB01582MIG
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
15488
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
1546417
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | RxNorm | ||
|
47324-98-1
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
4IK22DF4OU
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
C83659
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY | |||
|
4IK22DF4OU
Created by
admin on Mon Mar 31 17:58:54 GMT 2025 , Edited by admin on Mon Mar 31 17:58:54 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |